The Boomer Esiason Foundation (BEF) recently launched an awareness campaign for Team Boomer, its effort to encourage the cystic fibrosis (CF) community to…
PatrĂcia Silva, PhD
PatrĂcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĂcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by PatrĂcia Silva, PhD
Harvard Assets, a Pennsylvania-based provider of bullion and investment-grade diamond, recently renewed its support to the Cystic Fibrosis Foundation (CFF)…
The Cystic Fibrosis Foundation’s 2015 Ultimate Golf Experience, which ran four days beginning on Oct. 21, raised $630,000 towards continuing the organization’s…
The Strategies to Realize Innovation, Vision and Empowerment (STRIVE) Awards, which are granted by PTC Therapeutics, Inc., will now include…
The burden of cystic fibrosis (CF) is both physical and psychological for those with the disease — a…
The British non-profit organization Cystic Fibrosis Trust has launched a survey entitled “Cystic Fibrosis & Treatment – What…
Mechelen, Belgium-based biotech company Galapagos NV is presenting promising research findings at this year’s North American Cystic Fibrosis Conference…
Thousands of health professionals, disease experts, advocates, investors, and even patients and their families will be flocking to the Phoenix…
Raptor Pharmaceutical Corp., a global biopharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating and…
Two clinical-stage companies with investigational products for the cystic fibrosis treatment market have just announced their attendance and participation at the…